Crossmark

Association between increased mortality and bronchial fibroscopy in intensive care units and intermediate care units during COPD exacerbations: an analysis of the 2014 and 2015 National French Medical-based Information System Databases (PMSI)

Crossref DOI link: https://doi.org/10.1186/s40560-021-00560-w

Published Online: 2021-06-15

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Amalric, Matthieu

Ahmed, Engi

Jung, Boris

Suehs, Carey

Molinari, Nicolas

Bourdin, Arnaud

Charriot, Jeremy https://orcid.org/0000-0002-1420-5774
License Information

Text and Data Mining valid from 2021-06-15

Version of Record valid from 2021-06-15
More Information

Article History

Received: 17 February 2021

Accepted: 7 June 2021

First Online: 15 June 2021

Declarations

:

: This study was approved by the ethics committee of the University Hospital of Montpellier.

: We give the publisher the permission of the author to publish the work.

: MA, EA, BJ, CS, NM, and JC declare that they have no competing interests.Dr. Bourdin reports grants, personal fees, non-financial support, and others from GSK; grants, personal fees, non-financial support and others from Astra Zeneca; grants, personal fees, non-financial support and others from Boehringer Ingelheim; personal fees, non-financial support and others from Novartis; personal fees, non-financial support and others from Chiesi Farma; non-financial support and others from Teva; personal fees, non-financial support and others from Sanofi Regeneron; grants, personal fees, non-financial support and others from Actelion/Jansen; other from United Therapeutics; other from Pulsar; and personal fees, non-financial support and others from Roche outside the submitted work.

Document is current

Any future updates will be listed below